These filings confirm the completion of a reverse merger where InMed Pharmaceuticals became the public parent of Mentari Therapeutics. Monitor future filings for the combined entity's operating results and any additional insider transactions that may signal confidence or concern.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 13 $18.60entry
- T+1 · 20h ago +6.83%α +8.74% · $19.87
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Form 3 filings were filed by new insiders (Laura Sandler, Michelle Pernice, Julianne Bruno) of Mentari Therapeutics, Inc. (formerly InMed Pharmaceuticals Inc.), each accompanied by a power of attorney. The filings disclose shares received in a merger that closed on November 6, 2026, where InMed Pharmaceuticals (the issuer) acquired Pre-Merger Mentari via a two-step merger. Pernice received 27,868 shares (19,740 restricted), Bruno received 33,442 shares (23,689 restricted), and Sandler's holdings are not stated. These are routine initial ownership filings following a reverse merger and do not convey new material information about the company's operations or financials.
Key Facts
- Three Form 3 filings were filed on November 12, 2026, for the period ending November 6, 2026.
- The filings relate to a merger effective November 6, 2026, where InMed Pharmaceuticals Inc. (issuer) acquired Pre-Merger Mentari Therapeutics via a two-step merger.
- Michelle Pernice received 27,868 shares of common stock (19,740 restricted, vesting through August 2029) in exchange for Pre-Merger Mentari shares at a ratio of 0.20065.
- Julianne Bruno received 33,442 shares of common stock (23,689 restricted, vesting through August 2029) in exchange for Pre-Merger Mentari shares at a ratio of 0.20065.
- Laura Sandler's share count is not disclosed in the filing.
- Each filing includes a power of attorney authorizing Jerad Seurer, Brett Hagen, Ryan Murr, and Branden Berns to file Forms 3, 4, and 5 on behalf of the reporting person.
Financial Impact
No financial impact from these filings; they are administrative ownership disclosures following a merger.
Risk Factors
- No material risks identified from these routine filings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 12 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (MTRI), Batch item 1 | 0001193125-26-458259 |
| Document: 0001193125-26-458259-index-headers.html | 0001193125-26-458258 |
| Document: 0001193125-26-458259-index.html | 0001193125-26-458257 |
| Document: 0001193125-26-458259.txt | 0001193125-26-458259 |
| 3 Filing (MTRI), Batch item 5 | 0001193125-26-458258 |
| Document: 0001193125-26-458258-index-headers.html | 0001193125-26-458259 |
| Document: 0001193125-26-458258-index.html | 0001193125-26-458259 |
| Document: 0001193125-26-458258.txt | 0001193125-26-458259 |
| 3 Filing (MTRI), Batch item 9 | 0001193125-26-458257 |
| Document: 0001193125-26-458257-index-headers.html | 0001193125-26-458259 |
| Document: 0001193125-26-458257-index.html | 0001193125-26-458259 |
| Document: 0001193125-26-458257.txt | 0001193125-26-458259 |
Track record
10 reports on MTRI
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $17.90 Now $19.87 −11.01% settles Dec 15
- Nov 16, 2026today 8-K Neutral 6/10 Entry $18.60 Now $19.87 +6.83% settles Dec 15
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $19.02 Now $19.87 +4.47% settles Dec 15
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $15.75 Now $19.87 +26.16% settles Dec 15
- Nov 12, 20264d ago SC 13D Neutral 5/10 Entry $18.60 Now $19.87 +6.83% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $18.60 Now $19.87 +6.83% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $18.60 Now $19.87 +6.83% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Viewing Entry $18.60 Now $19.87 +6.83% settles Dec 14
- Nov 10, 20266d ago 8-K Mixed 7/10 Entry $15.61 Now $19.87 +27.30% settles Dec 10
- Nov 9, 20267d ago Press Release Neutral 2/10 Entry $16.00 Now $19.87 +24.19% settles Dec 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers